Evaluation of long-term pulmonary functions after COVID-19 infection in children: a longitudinal observational cohort study.

IF 1.4 4区 医学 Q4 INFECTIOUS DISEASES Journal of Infection in Developing Countries Pub Date : 2024-12-31 DOI:10.3855/jidc.20123
Muhammet F Korkmaz, Gülsüm E Şenkan, Şefika Elmas Bozdemir, Merve Korkmaz, İbrahim Koç, Behiye Oral
{"title":"Evaluation of long-term pulmonary functions after COVID-19 infection in children: a longitudinal observational cohort study.","authors":"Muhammet F Korkmaz, Gülsüm E Şenkan, Şefika Elmas Bozdemir, Merve Korkmaz, İbrahim Koç, Behiye Oral","doi":"10.3855/jidc.20123","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>We aimed to present the changes that may occur in pulmonary functions in children who experienced more severe coronavirus disease 2019 (COVID-19) during long-term follow-up.</p><p><strong>Methodology: </strong>A prospective longitudinal observational cohort study was conducted with 34 pediatric patients (7-18 years) who were hospitalized with COVID-19 infection (moderate n = 25, severe n = 9), and followed up at our Pediatric Infection Outpatient Clinic for approximately two years. Pulmonary function tests (PFTs) were performed using spirometry.</p><p><strong>Results: </strong>Data from the hospitalization period revealed no significant differences between the severity groups in terms of demographic, clinical, laboratory, radiological, treatment, and outcome (p > 0.05). The median time interval between COVID-19 infection and PFTs was 15 months (range 11-29 months), and there was no significant difference between severity groups (p = 0.878). Eight patients (24%) had abnormal pulmonary functions; among them, seven had an obstructive pattern (21%) and one had a restrictive pattern (3%). The severity groups had no statistical difference in pulmonary functions (p = 0.105). While forced expiratory volume in 1 second (FEV1) %, FEV1/forced vital capacity (FVC)%, and forced expiratory flow during the middle half of FVC (FEF25-75%) ratios were lower in the severe patient group, Z-scores were similar. Among the patients continuing polyclinic follow-up, 41% had persistent respiratory symptoms before PFTs. No differences were observed in PFTs when compared based on the presence of symptoms (p > 0.05).</p><p><strong>Conclusions: </strong>We observed no significant long-term differences in pulmonary function between moderate and severe COVID-19 cases in children.</p>","PeriodicalId":49160,"journal":{"name":"Journal of Infection in Developing Countries","volume":"18 12.1","pages":"S267-S274"},"PeriodicalIF":1.4000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection in Developing Countries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3855/jidc.20123","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: We aimed to present the changes that may occur in pulmonary functions in children who experienced more severe coronavirus disease 2019 (COVID-19) during long-term follow-up.

Methodology: A prospective longitudinal observational cohort study was conducted with 34 pediatric patients (7-18 years) who were hospitalized with COVID-19 infection (moderate n = 25, severe n = 9), and followed up at our Pediatric Infection Outpatient Clinic for approximately two years. Pulmonary function tests (PFTs) were performed using spirometry.

Results: Data from the hospitalization period revealed no significant differences between the severity groups in terms of demographic, clinical, laboratory, radiological, treatment, and outcome (p > 0.05). The median time interval between COVID-19 infection and PFTs was 15 months (range 11-29 months), and there was no significant difference between severity groups (p = 0.878). Eight patients (24%) had abnormal pulmonary functions; among them, seven had an obstructive pattern (21%) and one had a restrictive pattern (3%). The severity groups had no statistical difference in pulmonary functions (p = 0.105). While forced expiratory volume in 1 second (FEV1) %, FEV1/forced vital capacity (FVC)%, and forced expiratory flow during the middle half of FVC (FEF25-75%) ratios were lower in the severe patient group, Z-scores were similar. Among the patients continuing polyclinic follow-up, 41% had persistent respiratory symptoms before PFTs. No differences were observed in PFTs when compared based on the presence of symptoms (p > 0.05).

Conclusions: We observed no significant long-term differences in pulmonary function between moderate and severe COVID-19 cases in children.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
引言我们旨在介绍在长期随访过程中,经历过更严重的冠状病毒病2019(COVID-19)的儿童肺功能可能发生的变化:我们对 34 名因感染 COVID-19 而住院的儿童患者(7-18 岁)(中度 25 人,重度 9 人)进行了前瞻性纵向观察队列研究,并在儿科感染门诊进行了约两年的随访。肺功能测试(PFT)采用肺活量测定法进行:住院期间的数据显示,严重程度组之间在人口统计学、临床、实验室、放射学、治疗和结果方面没有显著差异(P > 0.05)。从感染 COVID-19 到进行 PFT 检查的中位时间间隔为 15 个月(11-29 个月),严重程度组之间无明显差异(P = 0.878)。八名患者(24%)肺功能异常,其中七名为阻塞型(21%),一名为限制型(3%)。严重程度组的肺功能无统计学差异(P = 0.105)。虽然重症患者组的 1 秒用力呼气容积(FEV1)%、FEV1/用力肺活量(FVC)% 和 FVC 中半部分的用力呼气流量(FEF25-75%)比率较低,但 Z 评分相似。在继续接受多家医院随访的患者中,41% 的患者在进行 PFT 检查前有持续的呼吸道症状。根据症状的存在情况进行比较,未观察到 PFT 的差异(P > 0.05):我们观察到,儿童 COVID-19 中度和重度病例的肺功能没有明显的长期差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.70
自引率
5.30%
发文量
239
审稿时长
4-8 weeks
期刊介绍: The Journal of Infection in Developing Countries (JIDC) is an international journal, intended for the publication of scientific articles from Developing Countries by scientists from Developing Countries. JIDC is an independent, on-line publication with an international editorial board. JIDC is open access with no cost to view or download articles and reasonable cost for publication of research artcles, making JIDC easily availiable to scientists from resource restricted regions.
期刊最新文献
A cross-sectional study on the prevalence of multidrug-resistant clinical isolates of Proteus species in Northern Iran. Antimicrobial consumption and resistance in a tertiary care hospital in Brazil: a 7-year time series. Epidemiologic threats and outcome of evolving COVID-19-associated mucormycosis from a referral hospital in Egypt. Assessing the capacity to implement the international health regulations to control COVID-19 at points of entry in Eswatini. COVID-19 mortality among solid organ transplant recipients and candidates before specific vaccine availability in Colombia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1